The use of antiviral COVID-19 medications can successfully inhibit SARS-CoV-2 replication
and prevent disease progression to a more severe form. However, the timing of antiviral …

Remdesivir is one nucleotide analogue prodrug capable to terminate RNA synthesis in
SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) by two distinct mechanisms …

Ciclesonide is an inhaled corticosteroid used to treat asthma and has been repurposed as a
treatment for mildly ill COVID-19 patients, but its precise mechanism of action is unclear …

In Belgium, multiple guidances are in use by clinicians concerning the management of
patients with COVID-19 but specific recommendations for the treatment of non-severe …

Identifying novel antivirals requires significant time and resource investment, and the
continuous threat of viruses to human health necessitates commitment to antiviral …

Ciclesonide is an inhaled corticosteroid used to treat asthma and has been repurposed as a
treatment for mildly ill COVID-19 patients, but its precise mechanism of action is unclear …

In only two years, the coronavirus disease 2019 (COVID-19) pandemic has had a
devastating effect on public health all over the world and caused irreparable economic …

Purpose: Coronavirus disease 2019 (COVID-19) has emerged as a serious threat to public
health; anticancer-repositioning treatment strategy has been formulated to treat the disease …

Introduction With the abrupt establishment of the COVID-19 pandemic, treatment for
immunological diseases may be influenced by the SARS-CoV-2 infection. Immunobiologics …

Abstract Despite corticosteroids, biomarkers, SpO 2/FiO 2, and racial/ethnic groups have
been associated with mortality in Severe COVID-19 Pneumonia. This is a secondary …